Skip to main content

EQT — Portfolio, Page 5

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

296
Companies
$4.4B
Total invested
$103.7M
Avg. check
50
Industries
Health Care 10Biotechnology 6Artificial Intelligence (AI) 4Software 4Medical 4Medical Device 4+44 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 97–120 of 296
Hume AI
March 2024

Hume AI is a research lab and technology company building AI systems with emotional intelligence.

Artificial Intelligence (AI) · New York$50.0M Series B
Nouscom
March 2024

Nouscom is a biotech company that develops a series of immunotherapies that are capable of selectively killing tumor cells.

Biotechnology · Basel$7.6M Series C
Griffin
March 2024

Griffin is a banking-as-a-service provider that helps companies build and launch financial services products.

Banking · London$24.4M Series A
Phagenesis
March 2024

Phagenesis is engaged in the development of a device to treat dysphagia, a condition that disables the safe swallowing of food.

Biotechnology · Manchester$42.0M Series D
Heart Aerospace
February 2024

Heart Aerospace is a Swedish startup making electric regional airplanes.

Aerospace · Goteborg$107.0M Series B
Packmatic
January 2024

Packmatic is a digital product packaging platform that sources packing solutions.

Digital Media · Berlin$16.3M Series A
Onera Health
January 2024

Onera Health is a global leader in sleep diagnostics and monitoring.

Health Care · Eindhoven$32.6M Series C
1X
January 2024

1X is an engineering and robotics company that develops humanoid robots designed to work alongside humans.

Artificial Intelligence (AI) · Moss$99.9M Series B
Vara
January 2024

Vara develops a breast cancer screening platform powered by AI.

Artificial Intelligence (AI) · Berlin$8.8M Series A
LUMA Vision
December 2023

LUMA Vision develops a 4D imaging and navigation end-to-end platform for cardiac applications, focusing on point-of-therapy data delivery.

Health Care · Harold's Cross$21.8M Series A
VectorY
November 2023

VectorY is an integrated gene therapy company focused on development of therapeutics for CNS, somatic disorders and muscle diseases.

Biotechnology · Amsterdam$138.0M Series A
Minervax
October 2023

Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.

Biotechnology · Hellerup$57.4M Venture - Series Unknown
Billhop
September 2023

Billhop is a Payment Institution which enables businesses and consumers to Pay bills and invoices with your credit card.

Billing · Stockholm$7.9M Venture - Series Unknown
Xeltis
August 2023

Xeltis is a clinical-stage medtech company with the world's most advanced polymer-based platform of restorative cardiovascular devices.

Health Care · Eindhoven$13.6M Series D
Noya
April 2023

Noya is reversing climate change and pulling CO2 out of the sky by retrofitting existing pieces of equipment to capture carbon.

Carbon Capture · San Francisco$22.0M Series A
VECTARY
January 2023

VECTARY is a design platform that specializes in the fields of augmented reality, computer vision, and 3D technology.

3D Technology · Redwood City$4.6M Venture - Series Unknown
Supernormal
January 2023

Supernormal is an AI platform that writes your meeting notes

Artificial Intelligence (AI) · Stockholm$10.0M Seed
ViCentra
January 2026

ViCentra has developed an insulin pump for diabetes patients.

Health Care · Utrecht$13.0M Series D
Kasada
December 2025

Kasada protects online, mobile, and API channels from system takeover, content scraping, DOS, and account takeover.

Computer · Sydney$19.9M Venture - Series Unknown
Mambu
December 2021

Mambu is the only true SaaS cloud core banking platform.

Banking · Amsterdam$265.4M Series E
Tenpoint Therapeutics
January 2026

Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.

Biotechnology · Camborne$150.0M Debt Financing
Atalanta Therapeutics
January 2025

Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.

Biotechnology · Boston$97.0M Series B
FastAF Technologies
December 2021

FastAF Technologies is a commerce retailer that delivers essential products.

Delivery Service · San Francisco$50.0M Series A
Watt Fuel Cell
December 2022

WATT Fuel Cell is a developer and manufacturer of solid oxide fuel cell stacks.

Energy · Mount Pleasant Mills$82.3M Corporate Round

Where EQT invests

Health Care10
Biotechnology6
Artificial Intelligence (AI)4
Software4
Medical4
Medical Device4

About EQT's portfolio

How many companies has EQT invested in?▸

EQT has invested in 296 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does EQT invest in?▸

EQT's top investment sectors include Health Care, Biotechnology, Artificial Intelligence (AI), Software, Medical. The firm invests across 50 different industry categories.

What is EQT's largest investment?▸

Among tracked funding rounds, Mambu received $265.4M in a Series E round. EQT's total known invested capital is $4.4B.

What is the average investment size for EQT?▸

EQT's average investment size is $103.7M across its portfolio of 296 companies.

What are EQT's most recent investments?▸

Recent EQT portfolio additions include Hume AI, Nouscom, Griffin, Phagenesis, Heart Aerospace. These companies were founded in 2020 or later.

Reach the founders behind these 296 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →